Related Experiment Video
Updated: Sep 23, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Invasive Hemodynamic Predictors of Survival in Patients With Mitral Stenosis Secondary to Mitral Annular
Abdallah El Sabbagh1, Rick A Nishimura2, Mackram F Eleid2
1Department of Cardiovascular Diseases Mayo Clinic Jacksonville FL.
Insights
Mitral valve area (MVA) and mitral valve gradient (MVG) predict outcomes in mitral annular calcification-related mitral stenosis. MVA is a stronger predictor of mortality than MVG in these patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Hemodynamics
Background:
- Mitral annular calcification (MAC) is a common condition in older adults.
- MAC can lead to mitral stenosis (MS), affecting valve function.
- Prognostic hemodynamic parameters for MAC-related MS require further definition.
Purpose of the Study:
- To identify prognostic hemodynamic parameters in patients with MAC-related MS.
- To evaluate the predictive value of mitral valve area (MVA) and mitral valve gradient (MVG) on survival.
- To determine the independent predictors of mortality in this patient cohort.
Main Methods:
- Retrospective cohort study of 105 patients with MAC-related MS.
- Hemodynamic evaluation via transseptal catheterization.
- Measurement of MVA (Gorlin formula) and MVG using direct pressures.
Main Results:
- Poor survival observed: 1-year survival 76%, 5-year survival 40%.
- MVA and MVG were independent predictors of death after adjusting for confounders.
- MVA emerged as a superior predictor of mortality compared to MVG.
Conclusions:
- Survival is significantly limited in patients with MAC-related MS.
- MVA is a robust independent predictor of outcomes in this population.
- Hemodynamic parameters, particularly MVA, are crucial for risk stratification.
Abstract:
Background The aim of this study was to establish prognostic hemodynamic parameters in patients with mitral stenosis secondary to mitral annular calcification. Methods and Results A retrospective cohort of 105 patients undergoing transseptal catheterization for hemodynamic evaluation of mitral annular calcification-related mitral stenosis between 2004 and 2020 was studied. Mitral valve gradient (MVG) and mitral valve area (MVA; calculated by the Gorlin formula) were measured using direct left atrial and left ventricular pressures. The median age of the patients was 70.3 years (58.4-76.7 years), and 53.3% were women. The median MVA was 1.7 cm2 (1.3-2.3 cm2) and MVG was 7.3 mm Hg (5.3-10.3 mm Hg); left ventricular end-diastolic pressure was 17.6±28.3 mm Hg. During a median of 2.1 years (0.7-4.5 years), there were 63 deaths; 1- and 5-year survival were 76% and 40%, respectively. There was no association between left ventricular end-diastolic pressure and survival. After adjusting for age and comorbidities, both MVA (hazard ratio [HR], 0.50 per cm2; 95% CI, 0.34-0.73) and MVG (HR, 1.1 per mm Hg; 95% CI, 1.05-1.20) were independent predictors of death. Atrial fibrillation was also independently associated with mortality. When added to a combined model, MVA remained associated with death (HR, 0.51 per cm2; 95% CI, 0.33-0.79) while MVG was not. Conclusions In patients with mitral annular calcification-related mitral stenosis, survival was poor. MVA and MVG were independently associated with death, but MVA was a better predictor of outcomes.
More Related Videos
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management